COST-EFFECTIVENESS ANALYSIS OF OCRELIZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YANG H.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MEDICAL ECONOMICS Year:2017 | Volume:20 | Issue:10 Page(s): 1056-1065

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

COST-EFFECTIVENESS ANALYSIS OF OCRELIZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS

Author(s)

YANG H. | Issue Writer Certificate

Keywords

Not Registered.

Abstract

Cites

EFFECT OF ISOMETRIC EXERCISES ON ABILITY AND BALANCE OF PATIENTS WITH MULTIPLE SCLEROSIS

References

No record.

Cite

APA: Copy

YANG, H.. (2017). COST-EFFECTIVENESS ANALYSIS OF OCRELIZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS. JOURNAL OF MEDICAL ECONOMICS, 20(10), 1056-1065. SID. https://sid.ir/paper/704905/en

Vancouver: Copy

YANG H.. COST-EFFECTIVENESS ANALYSIS OF OCRELIZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS. JOURNAL OF MEDICAL ECONOMICS[Internet]. 2017;20(10):1056-1065. Available from: https://sid.ir/paper/704905/en

IEEE: Copy

H. YANG, “COST-EFFECTIVENESS ANALYSIS OF OCRELIZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS,” JOURNAL OF MEDICAL ECONOMICS, vol. 20, no. 10, pp. 1056–1065, 2017, [Online]. Available: https://sid.ir/paper/704905/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops